COMMUNIQUÉS West-GlobeNewswire

Akcea Recognizes First Global Familial Chylomicronemia Syndrome (FCS) Awareness Day
02/11/2018
Community focuses on elevating awareness of the burden of FCS and impact on daily living BOSTON, Nov. 02, 2018 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (NASDAQ:AKCA), an affiliate of Ionis Pharmaceuticals, Inc., [...]
Capricor Therapeutics to Provide Corporate Update at BIO-Europe Conference on Nov. 6
02/11/2018
Presentation to Focus on Company’s Therapeutic Pipeline for Duchenne Muscular Dystrophy and other Rare Diseases LOS ANGELES, Nov. 02, 2018 (GLOBE NEWSWIRE) -- Capricor Therapeutics, Inc . (NASDAQ: CAPR) will provide a [...]
Asterias Biotherapeutics to Report Third Quarter 2018 Results on November 12, 2018
02/11/2018
FREMONT, Calif., Nov. 02, 2018 (GLOBE NEWSWIRE) -- Asterias Biotherapeutics, Inc. (NYSE American: AST), a biotechnology company dedicated to developing cell-based therapeutics to treat neurological conditions associated [...]
Aleafia Launches Global Expansion with Proposed Equity Stake in Australian Licensed Cannabis Company
02/11/2018
Aleafia to Distribute Medical Cannabis, Provide Technical Expertise to CannaPacific TORONTO, Nov. 02, 2018 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSXV: ALEF: OTCQX: ALEAF, FRA: ARAH) (“ Aleafia “) and CannaPacific Pty [...]
111, Inc. Establishes Strategic Partnership with A. Menarini China Holding Co., Ltd
02/11/2018
SHANGHAI, China, Nov. 02, 2018 (GLOBE NEWSWIRE) -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform, today announced it has established a strategic partnership [...]
Digirad Corporation Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2018
02/11/2018
Discusses progress on new “HoldCo” strategy Announces sale of Telerhythmics business Approves a new Stock Buy Back Plan, replacing Dividends Reaffirms 2018 financial guidance for Revenue and Free Cash Flow and updates [...]
HMS Holdings Corp. Reports Third Quarter 2018 Results
02/11/2018
Record Quarterly Revenue of $154.3 Million Record Quarterly Commercial Revenue of $86.7 Million / YTD Commercial Revenue Up 24% Quarterly COB Revenue of $105.7 million / YTD COB Revenue Up 8% Full-Year 2018 Revenue [...]
Enzymatica AB: Enzymatica's rights issue is secured up to 100 percent
02/11/2018
Press release November 2, 2018 Enzymatica's rights issue is secured up to 100 percent Enzymatica announced on October 18, 2018 that the Board of Directors has decided to carry out a rights issue of a maximum of SEK 98.7 [...]
Curetis launches privately placed capital increase to raise up to €18.4 million
02/11/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, INTO OR WITHIN THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO [...]
Rule 2.9 Announcement
02/11/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 2 November 2018 [...]
OSE Immunotherapeutics Regains Worldwide Rights to its CD28 antagonist FR104 from Janssen Biotech
02/11/2018
OSE to pursue clinical development of FR104 to treat autoimmune diseases FR104’s good phase 1 clinical safety profile and first efficacy signal support phase 2 testing NANTES, France, Nov. 02, 2018 (GLOBE NEWSWIRE) -- [...]
INNATE PHARMA : clinical data featured as oral presentations at two major upcoming oncology conferences
02/11/2018
INNATE PHARMA CLINICAL DATA FEATURED AS ORAL PRESENTATIONS AT TWO MAJOR UPCOMING ONCOLOGY CONFERENCES Late-breaking abstract and oral presentation on clinical and translational biomarker results from the combination of [...]
INNATE PHARMA annonce la présentation de données cliniques à deux prochains congrès majeurs d'oncologie
02/11/2018
Innate Pharma annonce la présentation de données cliniques lors de sessions orales à deux prochains congrès majeurs d'oncologie Présentation orale de résultats cliniques et translationnels sur les biomarqueurs de la [...]
Abiomed annonce un chiffre d'affaires record de 182 millions $ pour le deuxième trimestre 2019, soit une hausse de 37 % par rapport au trimestre équivalent de l'exercice précédent
02/11/2018
DANVERS, Massachusetts, 02 nov. 2018 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ: ABMD), un fournisseur majeur de technologies innovantes de récupération et d'assistance cardiaque, a annoncé aujourd'hui un chiffre d' [...]
VANC Pharmaceuticals Inc. Provides Corporate Update
02/11/2018
VANCOUVER, British Columbia, Nov. 01, 2018 (GLOBE NEWSWIRE) -- VANC Pharmaceuticals Inc. ( “VANC” ) is excited to announce that further to its news release announced October 25, 2018, the Company has received TSX [...]
CV Sciences, Inc. to Sponsor 25th Anniversary HIACON Conference in Los Angeles, California on Nov 2-5, 2018
01/11/2018
As 2018 Farm Bill Momentum Rises, CV Sciences and Hemp Industries Association are ‘Charting The Course’ LAS VEGAS, Nov. 01, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB: CVSI) preeminent supplier and manufacturer [...]
New learning technology adds ‘significant boost’ to prescribing safety in Canada
01/11/2018
LONDON and OTTAWA, Nov. 01, 2018 (GLOBE NEWSWIRE) -- The Royal College of Physicians and Surgeons of Canada (Royal College) has today taken a vital step towards championing Canadian patient safety, by introducing a [...]
De nouveaux modules d’apprentissage renforcent les compétences en prescription au Canada
01/11/2018
LONDRES et OTTAWA , 01 nov. 2018 (GLOBE NEWSWIRE) -- Le Collège royal des médecins et chirurgiens du Canada (Collège royal) s’affirme une fois de plus en tant qu’ardent défenseur de la sécurité des patients canadiens en [...]
Portola Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
01/11/2018
SOUTH SAN FRANCISCO, Calif., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® (NASDAQ: PTLA) announced today that on October 26, 2018, the Compensation Committee of the Board of Directors approved, [...]

Pages